Sharemaestro Newsreel

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

Revvity, Inc. RVTY recently announced the launch of the SuperFlex prenatal screening system, a compact, CE-IVDR-certified automated immunoassay instrument designed to expand access to prenatal and preeclampsia testing. Purpose-built for small to mid-sized laboratories and clinics, the platform is intended to bring reliable, rapid …

OPKO Issues $125M Notes While Keeping Future Mazdutide Royalties

OPKO Health (NASDAQ: OPK) has expanded its financing relationship with HealthCare Royalty by issuing an additional $125 million in senior secured notes, backed by royalty interests from its mazdutide license with Eli Lilly. These notes mature in 2044, and the agreement caps total payments …

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests

OPKO Health has expanded its financing relationship with HealthCare Royalty (HCRx), a KKR business, by issuing an additional $125 million in senior secured notes. These notes are backed by OPKO's royalty interests from its mazdutide license agreement with Eli Lilly and Company, maturing in …

Sotera Health (SHC) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Jason Peterson Executive Chairman - Michael Petras Chief Executive Officer - Alton Shader Chief Financial Officer - Jonathan Lyons Full Conference Call …

National Vision Stock Down Despite Q2 Earnings & Revenue Beat

National Vision Holdings, Inc. reported stronger-than-expected Q2 2026 earnings and revenues, with adjusted earnings per share of 25 cents beating estimates by 47.1% and net revenues rising 2.5% year over year. Despite the beat and an expanded operating margin, the company's stock fell 7.9% …

Luxembourg: Dirk Bontridder appointed CEO of Astorg’s microbiology diagnostics business following completion of acquisition from Thermo Fisher Scientific

Dirk Bontridder has been appointed CEO of the newly independent microbiology diagnostics platform formed after Astorg completed its acquisition of Thermo Fisher Scientific's global microbiology business. Bontridder brings over 25 years of international leadership experience from the life sciences, diagnostics, and industrial technology sectors, …

Agilent Technologies stock holds steady as earnings beat and new analyst target support valuation

Agilent Technologies (A) stock is holding steady after reporting stronger-than-expected Q2 2026 earnings per share of $1.49 and 10% revenue growth to $1.83 billion. The company also issued fiscal 2026 EPS guidance between $6.00 and $6.10, which analysts anticipate will be around $6.01. A …

Cingulate’s ADHD Drug Patent Protects Its Formulation Through 2042

Cingulate Inc. reported its second-quarter 2026 financial results, highlighting $28.4 million in cash and cash equivalents, expected to fund operations into mid-2027. The company is advancing its CTx-1301 ADHD drug toward NDA resubmission following an FDA Complete Response Letter and secured a new U.S. …

TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises

Bio-Techne Corporation (TECH) reported Q4 fiscal 2026 adjusted earnings per share of 52 cents, meeting Zacks Consensus Estimates, while net sales of $321.2 million surpassed expectations. Despite some mixed segment performances and a contraction in adjusted gross margin, the company's shares rose slightly. The …

Check-Cap (MBAI) Advances Merger with MBody AI; Reverse Share Split Effective

Check-Cap Ltd. (NASDAQ: MBAI) advanced its proposed merger with physical AI company, MBody AI Corp., completing a planned 1-for-7 reverse share split ISFIYA, Israel and LAS VEGAS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. ("Check-Cap" or the "Company") (NASDAQ: MBAI) today announced that …

Will FDA Clearance of QIAstat-Dx Bloodstream Panel Change Qiagen's (QGEN) Syndromic Testing Narrative?

Earlier this week, QIAGEN reported second-quarter 2026 results showing essentially flat year-on-year sales at US$535.04 million but higher net income of US$103.4 million, alongside shareholder-approved changes to its Articles that enable a reverse stock split and a capital repayment of up to US$200 million. …

3 Large-Cap Stocks We Find Risky

3 Large-Cap Stocks We Find Risky Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they've already captured significant portions of …

This Healthcare Services Stock Has 37% Upside

Well-known pharmaceutical companies such as Merck and Pfizer typically manage this complex process in house. Medpace Holdings which targets oncology, metabolic, cardiology, central nervous system, and anti-infective therapies, raised its 2026 revenue guidance on July’s second-quarter conference call to a midpoint of $2.85 billion, …

Quest Diagnostics Incorporated (NYSE:DGX) Plans Quarterly Dividend of $0.86

Quest Diagnostics (NYSE:DGX) has declared a quarterly dividend of $0.86 per share, payable on October 21st to shareholders of record on October 6th. This dividend represents an annualized payout of $3.44 and a 1.4% yield. The company has a strong dividend history, having increased …

Mettler Toledo International (MTD) Reports Stronger Earnings, Is The Stock Fully Valued?

28,409 Shares in Agilent Technologies, Inc. $A Acquired by Oak Thistle LLC

Oak Thistle LLC acquired 28,409 shares of Agilent Technologies (NYSE:A) in the second quarter, valued at approximately $3.77 million, with several other institutional investors also initiating positions. Analysts have a "Moderate Buy" consensus rating for Agilent with an average price target of $160.24, following …

Y Intercept Hong Kong Ltd Cuts Stock Position in Thermo Fisher Scientific Inc. $TMO

Y Intercept Hong Kong Ltd significantly reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 84.1% in the second quarter, selling 14,076 shares and retaining 2,669 shares valued at $1.34 million. Despite this, Thermo Fisher Scientific reported strong quarterly earnings, beating analyst estimates …

Agilent Technologies, Inc. $A Shares Acquired by Handelsbanken Fonder AB

Handelsbanken Fonder AB has increased its stake in Agilent Technologies (NYSE:A) by 34.4% during the second quarter, now owning 162,195 shares valued at $21.54 million. Other institutional investors also adjusted their positions in the medical research company. Agilent Technologies has received a "Moderate Buy" …

Fund Update: 22,749 THERMO FISHER SCIENTIFIC (TMO) shares added to Magellan Asset Management Ltd portfolio

Magellan Asset Management Ltd has increased its stake in Thermo Fisher Scientific (TMO) by adding 22,749 shares to its portfolio, as per a recent SEC 13F filing. The article also details significant institutional investor activity, insider trading, government contracts, congressional stock trading, and analyst …

President of Sterigenics U.S. Of Sotera Health Sold 37% Of Their Shares

The President of Sterigenics U.S., Michael Rutz, recently sold 37% of his shares in Sotera Health Company (NASDAQ:SHC) for approximately US$2.8 million. This sale follows another significant insider sale by the Executive Chairman of the Board, Michael Petras, worth US$12 million over the past …

Sheets Smith Wealth Management Raises Holdings in Thermo Fisher Scientific Inc. $TMO

Sheets Smith Wealth Management significantly increased its stake in Thermo Fisher Scientific Inc. by 47.3% in the second quarter, bringing its total holdings to 5,200 shares valued at $2.61 million. This comes as Thermo Fisher Scientific reported strong quarterly earnings, beating analyst estimates with …

Trinity Street Asset Management LLP Raises Stock Position in Icon Plc $ICLR

Trinity Street Asset Management LLP significantly increased its stake in Icon Plc (NASDAQ:ICLR) by 27.1% in the second quarter, making it their second-largest holding. This comes as Icon reported slightly better-than-expected quarterly results, though earnings were down year-over-year. Analysts currently hold a "Hold" rating …

Handelsbanken Fonder AB Has $18.10 Million Stock Position in Mettler-Toledo International, Inc. $MTD

Handelsbanken Fonder AB increased its stake in Mettler-Toledo International, Inc. by 11.4% in the second quarter, now owning 14,165 shares valued at $18.1 million. Despite this, company insiders have sold over $4.75 million worth of shares recently, including significant sales by the CFO. Analysts …

576,266 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Wasatch Advisors LP

Wasatch Advisors LP has acquired 576,266 shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) worth approximately $12.4 million, bringing institutional ownership in the company to 99.17%. Despite a reported wider-than-expected quarterly loss, Adaptive Biotechnologies saw a 21.5% year-over-year revenue increase. The stock is trading near its …

IDEXX (IDXX) Stock Looks Fair On Cash Flow But Rich On Earnings

Agilent Technologies, Inc. $A Shares Sold by Gateway Investment Advisers LLC

Gateway Investment Advisers LLC significantly reduced its stake in Agilent Technologies, Inc. (NYSE:A) by 82.9% in the second quarter, selling over 60,000 shares. Despite this, other institutional investors like Mitsubishi UFJ Asset Management Co. Ltd. and Mirae Asset Global Investments Co. Ltd. increased their …

Bank of America Corp DE Grows Stock Position in Veracyte, Inc. $VCYT

Bank of America Corp DE increased its stake in Veracyte, Inc. by 14.7% in the first quarter, holding 1.45 million shares valued at $46.7 million. Other institutional investors also raised their positions, and analysts maintain a "Moderate Buy" rating with an average target price …

Adaptive Biotechnologies (ADPT) CCO Bobulsky sells 3,000 shares under plan

Adaptive Biotechnologies' Chief Commercial Officer, MRD, Susan Bobulsky, sold 3,000 shares of common stock at $25.00 per share on August 10, 2026. This transaction was conducted under a Rule 10b5-1 trading plan established on December 16, 2025. Following the sale, Bobulsky directly holds 396,989 …

Mettler-Toledo International, Inc. (NYSE:MTD) Given Consensus Rating of "Hold" by Analysts

Mettler-Toledo International, Inc. (NYSE:MTD) has received a "Hold" consensus rating from analysts, with seven out of thirteen recommending holding the stock and six suggesting a buy. The average 12-month price target is set at approximately $1,461. The company recently surpassed quarterly earnings expectations, reporting …

Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts

Revvity Inc. (NYSE:RVTY) has received an average "Hold" recommendation from analysts, with 12 out of 15 rating it a hold and three a buy. Despite exceeding quarterly earnings and revenue expectations, the company's revenue declined 1.3% year over year, and the average 12-month price …

Adaptive Biotechnologies (ADPT) Stock Looks Fair On Cash Flow Yet Rich On Sales

Adaptive Biotechnologies (ADPT) stock appears fairly valued based on its discounted cash flow model, which places its intrinsic value close to its current share price. However, the stock looks expensive when evaluated using market multiples, particularly its P/S ratio, which is significantly higher than …

The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call

The Top 5 Analyst Questions From Revvity's Q2 Earnings Call Revvity's second quarter demonstrated year-over-year growth in both revenue and non-GAAP earnings, yet the market responded negatively, likely reflecting concerns about underlying segment dynamics and external factors. Management highlighted continued strength in its Diagnostics …

Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?

IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected …

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Susan Bobulsky Sells 3,000 Shares of Stock

Susan Bobulsky, an insider at Adaptive Biotechnologies (NASDAQ:ADPT), sold 3,000 shares of the company's stock for $75,000, reducing her total holdings by 0.75%. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Despite the sale, institutional investors own a significant 99.17% of …

Adaptive Biotechnologies CCO Susan Bobulsky sells $75,000 in shares By Investing.com

Adaptive Biotechnologies' Chief Commercial Officer, Susan Bobulsky, sold 3,000 shares of common stock totaling $75,000 at $25.00 per share on August 10, 2026. This transaction was executed under a Rule 10b5-1 trading plan and occurred while the stock was trading near its 52-week high …

Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6

Quest Diagnostics (DGX) announced that it will maintain its quarterly dividend at $0.86 per share. This dividend will be payable on October 21, 2026, to shareholders of record as of October 6, 2026. The announcement was published on August 12, 2026, by MT Newswires.